Risk of second primary cancers in cancer patients treated with cisplatin: a systematic review and meta-analysis of randomized studies

BACKGROUND: Case reports, retrospective analyses, and observational studies have linked the use of cisplatin to increased risk of second cancers, especially life-threatening secondary leukemia. We therefore performed a systematic review and meta-analysis to evaluate the risk of second cancers associ...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Fei, Zhang, Sheng, Xue, Hongxi, Chen, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738212/
https://www.ncbi.nlm.nih.gov/pubmed/29258467
http://dx.doi.org/10.1186/s12885-017-3902-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738212/
https://www.ncbi.nlm.nih.gov/pubmed/29258467
http://dx.doi.org/10.1186/s12885-017-3902-4

Ejemplares similares